naringenin
Selected indexed studies
- Naringenin: A potential flavonoid phytochemical for cancer therapy. (Life Sci, 2022) [PMID:35779626]
- Naringenin Nanoformulations for Neurodegenerative Diseases. (Curr Pharm Biotechnol, 2024) [PMID:38347794]
- Naringenin: its chemistry and roles in neuroprotection. (Nutr Neurosci, 2024) [PMID:37585716]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Naringenin: A potential flavonoid phytochemical for cancer therapy. (2022) pubmed
- Naringenin Nanoformulations for Neurodegenerative Diseases. (2024) pubmed
- Naringenin: its chemistry and roles in neuroprotection. (2024) pubmed
- Naringenin: A flavanone with anti-inflammatory and anti-infective properties. (2023) pubmed
- Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe(-/-)mice: role of SIRT1. (2021) pubmed
- Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice. (2020) pubmed
- Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease. (2022) pubmed
- Naringenin as a potential immunomodulator in therapeutics. (2018) pubmed
- Naringenin and naringin in cardiovascular disease prevention: A preclinical review. (2020) pubmed
- Naringenin/naringin therapeutic effects and the role of intestinal microflora in them. (2025) pubmed